ArticleFrontiers in oncology2024

Sorafenib maintenance after allogeneic stem cell transplantation in patients with FLT3+ AML receiving midostaurin during induction and consolidation: a retrospective analysis.

Giuseppe Sapienza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.